2/19/2025 6:32:40 PM The Landscape of Regeneron’s Eylea® Litigation After the Federal Circuit Affirmed Two Preliminary Injunction Orders Blocking Biosimilar Market Entry By Dan Liu A biosimilar is a biologic drug that is highly similar, but not identical, to an already approved biologic drug, i.e. the reference...
2/15/2025 12:30:38 AM President Trump Quietly Nominates OCC and CFPB Leadership By Melissa Hall In the midst of the flurry of nominations and appointments to federal agencies, President Trump has appointed an acting chair of the...
2/14/2025 7:59:05 PM Bankruptcy Court Clarifies Priority of Liens on Collateral Subject to a Certificate of Title Statute By Bethany D. Simmons Noah Weingarten In In re K & L Leasing, Inc., 665 B.R. 364 (Bankr. E.D. Tenn. 2024), the U.S. Bankruptcy Court for the Eastern District of Tennessee held...
2/14/2025 3:24:26 PM Federal Court Holds that Creator of AI Tool Infringed Copyright in Training Data: Harbinger or Blip? By Frank D. D'Angelo On February 11, 2025, a federal district court in Delaware held that the developer of an artificial intelligence (AI) tool infringed the...
2/11/2025 7:09:47 PM Agentic AI Makes Its Super Bowl Appearance By Melanie J. Howard If you watched the Superbowl, you likely saw a commercial featuring Matthew McConaughey dashing through the airport trying to make a...